Board Committees & Regulations

Audit Committee

The Audit Committee’s overall mission is to assist the Board of Directors in monitoring issues related to the development and control of semi-annual and annual accounting and financial information as well as elements to assess the risks incurred by the Group. It examines the accounts prior to their presentation to the Board and gives views on the appointment and remuneration of the auditors as well as elements relating to their independence.

Danièle Guyot-Caparros

Chairperson of the Board of Directors
Chair of the Audit Committee

Julien Miara

Director, representing
Invus Public Equities LLP

Christine Garnier 

Independent Director

Compensation and Nomination Committee

The Compensation and Nomination Committee is to prepare the Board of Directors’ decisions concerning the selection and appointment of future directors,  the compensation of executive officers, determining performance conditions concerning the granting of warrants or options to purchase shares, or bonus shares for the executive officers and the periodic evaluation of directors’ compensation.
The members of the Compensation and Nomination Committee are selected among the directors of Onxeo or from among outside experts. They are appointed on a personal basis and cannot be represented. The directors who are members of the Compensation and Nomination Committee are appointed for the duration of their director’s mandate.

Thomas Hofstaetter

Chair of the Compensation and Nomination Committee
Independent Director

Nicolas Trebouta

Director, representing
Financière de la Montagne

Jean-Pierre Bizzari

Independent Director

R&D and Business Development Committee

By decision of September 17, 2020, this committee is replaced by specific sessions of the Board, led by Mr. Thomas Hofstaetter for the business development aspects, and by Mr. Jean-Pierre Bizzari for the R&D aspects.

Onxeo complies with the Middlenext corporate governance code (French only).